Volker Wagner MD PhD

Dr. Wagner joined Orano Med as Chief Medical Officer (CMO) in December 2023. He brings a wealth of experience and expertise to this role: as former Vice President and Head of Clinical Development Radiopharmaceuticals at Bayer, Dr. Wagner played a pivotal role in the development of Radium-223 (Xofigo®) and early Targeted Alpha Therapies. With over 20 years of dedicated service in oncology and the pharmaceutical industry, Dr. Wagner is a very seasoned Drug Development Executive with strong track record of success, building and leading high-performance Clinical Development and Medical Affairs organizations, both in Europe and the USA. 

Dr. Wagner is board certified in Internal Medicine, Medical Oncology, and Hematology.